The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oxaliplatin (OX), chronomodulated capecitabine, and UGT1A1 genotype-directed dosing of irinotecan (IR) triplet chemotherapy (OXIRI) in patients (pts) with advanced pancreatic cancer (APC).
 
Amanda Oon Lim Seet
No Relationships to Disclose
 
Sylvia Chen
No Relationships to Disclose
 
Yingnan Yu
No Relationships to Disclose
 
Su Pin Choo
Honoraria - Bayer; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Eisai; Novartis; Shire; Sirtex Medical
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Merck
 
David Wai-Meng Tai
No Relationships to Disclose
 
Justina Yick Ching Lam
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - MSD
 
Yvonne Chang
No Relationships to Disclose
 
Balram Chowbay
No Relationships to Disclose
 
Matthew CH Ng
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology
Research Funding - ASLAN Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Taiho Pharmaceutical